Interobserver variation in the assessment of HER2 low expression in breast cancer: can we improve by adjusting criteria? An international interobserver study. (November 2022) - Baez Navarro, X.; van Bockstal, M.R.; Nawawi, D.; Broeckx, G.; Colpaert, C.G.; Doebar, S.C.; Hogenes, M.C.H.; Koop, E.; Lambein, K.; Peeters, D.J.E.; Sinke, R.H.J.A.; van Brakel, J.B.; et al.